Rucaparib (acetate)

CAT:
804-HY-10617D
Size:
1 Each
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Rucaparib (acetate) - image 1

Rucaparib (acetate)

  • Description :

    Rucaparib (AG014699) acetate is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib acetate is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib acetate has the potential for castration-resistant prostate cancer (CRPC) research[1][2][3][4].
  • Product Name Alternative :

    AG014699 (acetate) ; PF-01367338 (acetate)
  • UNSPSC :

    12352005
  • Target :

    PARP
  • Type :

    Reference compound
  • Related Pathways :

    Cell Cycle/DNA Damage; Epigenetics
  • Applications :

    Cancer-programmed cell death
  • Field of Research :

    Cancer
  • Assay Protocol :

    https://www.medchemexpress.com/rucaparib-acetate.html
  • Solubility :

    10 mM in DMSO
  • Smiles :

    FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1.CC(O)=O
  • Molecular Formula :

    C21H22FN3O3
  • Molecular Weight :

    383.42
  • References & Citations :

    [1]Thomas HD, et al. Preclinical selection of a novel poly (ADP-ribose) polymerase inhibitor for clinical trial. Mol Cancer Ther, 2007, 6 (3), 945-956.|[2]J Murray, et al. Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules. Br J Cancer. 2014 Apr 15;110 (8) :1977-84.|[3]Matt Shirley, et al. Rucaparib: A Review in Ovarian Cancer. Target Oncol. 2019 Apr;14 (2) :237-246.|[4]Jianneng Li, et al. Hexose-6-phosphate dehydrogenase blockade reverses prostate cancer drug resistance in xenograft models by glucocorticoid inactivation. Sci Transl Med. 2021 May 26;13 (595) :eabe8226.|[5]Hunter JE, et al. NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699. Oncogene, 2012, 31 (2), 251-264.|[6]Daniel RA, et al. Inhibition of poly (ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma. Clin Cancer Res, 2009, 15 (4), 1241-1249.
  • Shipping Conditions :

    Room temperature
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    Launched
  • Isoform :

    PARP1; PARP2; PARP3
  • CAS Number :

    [773059-23-7]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide